HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hilditch, T. E. Articles by Reed, N. S. Search for Related Content PubMed PubMed Citation Articles by Hilditch, T. E. Articles by Reed, N. S.

Poor Results with Technetium-99m (V) DMS and Iodine-131 MIBG in the Imaging of Medullary Thyroid Carcinoma

West of Scotland Health Boards, Department of Clinical Physics and Bio-Engineering
MRC Blood Pressure Unit, West of Scotland Radionuclide Dispensary, and Glasgow Institute of Radiotherapeutics and Oncology, Western Infirmary, Glasgow, Scotland

Correspondence: For reprints contact: T.E. Hilditch, PhD, Dept. of Clinical Physics and Bio-Engineering, 11 West Graham St., Glasgow G4 9LF, Scotland.

ABSTRACT

The value of [^99mTc](V)DMS and [¹³¹I]MIBG in imaging medullary carcinoma of the thyroid was investigated in five patients. Results with [^99mTc](V)DMS were negative in all five patients as well as with [¹³¹I]MIBG in four patients; however, there was significant tumor uptake in one patient with [¹³¹I]MIBG.